Skip to main navigation

Main navigation

About Us
Commitments
- Innovation Hub
Products
Partnerships
- Grants
- Partnerships for the Future
News
- In The News
- Archive
Events
Investors
Careers

Home
Investors
In the News
Archive
Events

Pacira in the News

Recent News

Pacira Announces FDA Approval of Enhanced EXPAREL Manufacturing Process

08/02/21

New Analysis Shows iovera° Plays a Critical Role in Achieving Significant Reductions in Opioid Use, Pain Scores, and Hospital Stay Following Total Knee Arthroplasty

07/29/21

Pacira to Report Second Quarter 2021 Financial Results on Tuesday August 3, 2021

07/20/21

Pacira BioSciences Reports Record Revenue of $135.6 Million for the Second Quarter of 2021

07/13/21

Pacira Announces EXPAREL Distribution Agreement with Eurofarma in Latin America

06/22/21

Browse the press release archive

Shareholder Tools

Print Page
RSS Feeds
Email Alerts

Contact Us
Legal
Site Map
Privacy Notice

EXPAREL^® (bupivacaine liposome injectable suspension), the EXPAREL logo, iovera^o, the iovera^o logo, Pacira, and the Pacira logo are registered trademarks of Pacira BioSciences, Inc. All other trademarks referenced herein are the property of their respective owners.